BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28393368)

  • 1. Increased levels of the T-helper 22-associated cytokine (interleukin-22) and transcription factor (aryl hydrocarbon receptor) in patients with periodontitis are associated with osteoclast resorptive activity and severity of the disease.
    Díaz-Zúñiga J; Melgar-Rodríguez S; Rojas L; Alvarez C; Monasterio G; Carvajal P; Vernal R
    J Periodontal Res; 2017 Oct; 52(5):893-902. PubMed ID: 28393368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-22-expressing CD4
    Monasterio G; Budini V; Fernández B; Castillo F; Rojas C; Alvarez C; Cafferata EA; Vicencio E; Cortés BI; Cortez C; Vernal R
    J Periodontal Res; 2019 Oct; 54(5):513-524. PubMed ID: 31032952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis.
    Ertugrul AS; Sahin H; Dikilitas A; Alpaslan N; Bozoglan A
    J Periodontal Res; 2013 Feb; 48(1):44-51. PubMed ID: 22812409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gingival crevicular fluid levels of interferon-γ, but not interleukin-4 or -33 or thymic stromal lymphopoietin, are increased in inflamed sites in patients with periodontal disease.
    Papathanasiou E; Teles F; Griffin T; Arguello E; Finkelman M; Hanley J; Theoharides TC
    J Periodontal Res; 2014 Feb; 49(1):55-61. PubMed ID: 23550893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of interleukin (IL)-35 and IL-17, but not IL-27, in gingival tissues with chronic periodontitis.
    Mitani A; Niedbala W; Fujimura T; Mogi M; Miyamae S; Higuchi N; Abe A; Hishikawa T; Mizutani M; Ishihara Y; Nakamura H; Kurita K; Ohno N; Tanaka Y; Hattori M; Noguchi T
    J Periodontol; 2015 Feb; 86(2):301-9. PubMed ID: 25272982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients.
    Dutzan N; Vernal R; Vaque JP; García-Sesnich J; Hernandez M; Abusleme L; Dezerega A; Gutkind JS; Gamonal J
    J Periodontol; 2012 Jul; 83(7):948-54. PubMed ID: 22181687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of Interleukin-35 in Gingival Crevicular Fluid, Saliva, and Plasma in Periodontal Disease and Health.
    Köseoğlu S; Sağlam M; Pekbağrıyanık T; Savran L; Sütçü R
    J Periodontol; 2015 Aug; 86(8):964-71. PubMed ID: 25786564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gingival crevicular fluid and interleukin-23 concentration in systemically healthy subjects: their relationship in periodontal health and disease.
    Himani GS; Prabhuji ML; Karthikeyan BV
    J Periodontal Res; 2014 Apr; 49(2):237-45. PubMed ID: 23721589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease.
    Pradeep AR; Daisy H; Hadge P; Garg G; Thorat M
    J Periodontol; 2009 Sep; 80(9):1454-61. PubMed ID: 19722796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.
    Górska R; Gregorek H; Kowalski J; Laskus-Perendyk A; Syczewska M; Madaliński K
    J Clin Periodontol; 2003 Dec; 30(12):1046-52. PubMed ID: 15002890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.
    Yong X; Chen Y; Tao R; Zeng Q; Liu Z; Jiang L; Ye L; Lin X
    J Periodontal Res; 2015 Jun; 50(3):403-10. PubMed ID: 25065393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
    Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
    J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of Gingival Crevicular Fluid Interleukin-17, 18 and 21 in Different Stages of Periodontal Health and Disease.
    Nair V; Grover V; Arora S; Das G; Ahmad I; Ohri A; Sainudeen S; Saluja P; Saha A
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment.
    Gamonal J; Acevedo A; Bascones A; Jorge O; Silva A
    J Periodontol; 2000 Oct; 71(10):1535-45. PubMed ID: 11063385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
    Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
    J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis.
    Buduneli N; Özçaka Ö; Nalbantsoy A
    J Periodontol; 2012 Mar; 83(3):362-8. PubMed ID: 21859321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of scaling and root planing on interleukin-1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients.
    Konopka L; Pietrzak A; Brzezińska-Błaszczyk E
    J Periodontal Res; 2012 Dec; 47(6):681-8. PubMed ID: 22510045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease.
    Pradeep AR; Roopa Y; Swati PP
    J Periodontal Res; 2008 Dec; 43(6):712-6. PubMed ID: 18624944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
    Tüter G; Kurtiş B; Serdar M
    J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease.
    Kurşunlu SF; Oztürk VÖ; Han B; Atmaca H; Emingil G
    Arch Oral Biol; 2015 Jan; 60(1):77-83. PubMed ID: 25247780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.